Disclaimer: Note that the firm is no longer accepting cases for the anti-psychotic medication Abilify or Tylenol autism cases. Thank you.
Select Page

This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm.
As my regular readers are aware, I am the founder and Chair of the American Association for Justice’s (AAJ) Crestor Litigation Group, a collection of pharmaceutical mass tort attorneys dedicated to advancing litigation involving the harmful effects of treatment with the statin drug Crestor.
Since 2001 and my involvement with litigation involving the statin drug Baycol, I have been educating the public and my fellow attorneys on the dangers of statin medications. In addition to the risk of development of a life-threatening condition known as rhabdomyolysis, statin use can lead to kidney and liver failure. Crestor, a so-called “super-statin”, has been a target of an investigation into an association with the depletion of CoQ10 and the development of congestive heart failure and cardiomyopathy.
Now, troubling scientific evidence has been brought to light that shows a new (and long suspected) association with statin drugs such as Crestor and the development of diabetes. Dr. Yunsheng Ma of the University of Massachusetts Medical School led a study of postmenopausal women and nearly 10 percent of the statin users in the study group had developed diabetes, compared with 6.4 percent of the older women who hadn’t used the drugs at the study’s start. These disturbing findings were reported this week online in the journal Archives of Internal Medicine.
The AAJ Crestor Litigation group will be meeting in Phoenix, AZ next month at the AAJ Winter Convention to discuss these findings and other developments in Crestor litigation. I will keep my readers advised of all updates in this regard.
If you or someone you know has taken or is currently taking Crestor and has been diagnosed with cardiomyopathy or diabetes, please contact me directly for a free, no-obligation, evaluation of your Crestor claim

About the Firm: The Michael Brady Lynch Firm is a trial firm with a focus on pharmaceutical mass tort cases involving SSRI and Anti-Seizure Medication Birth Defects such as Lexapro, Zoloft, Effexor, Prozac, Celexa, Paxil, Depakote and Topamax, as well as Actos Bladder Cancer and Fosamax Femur Fractures, and medical device cases including DePuy Hip and Trans-Vaginal Mesh cases. Contact us today if you or someone you know has experienced side effects involving these products.


What Our Clients Are Saying